Pavunalimab Usage And Synthesis

Uses

Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer[1].

in vivo

References

[1] Perez-Santos M, et, al. Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents. Expert Opin Drug Discov. 2022 Nov 24;1-15. DOI:10.1080/17460441.2022.2148652

Pavunalimab(2329669-78-3)Related Product Information

• Dapirolizumab Pegol
• Etigilimab
• Lupartumab
• Briakinumab
• Tuvonralimab
• Zamerovimab
• Pimurutamab
• Cadonilimab
• Recaticimab
• Gatipotuzumab